Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 09

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 09

DOI: 10.23736/S1824-4785.21.03417-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Challenges in theragnostics

Laura EVANGELISTA 1 , Diego CECCHIN 1, Jolanta KUNIKOWSKA 2

1 Nuclear Medicine Unit, Department of Medicine - DIMED, Padua University Hospital, Padua, Italy; 2. Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland


PDF


Precision medicine (or personalized medicine) is an intriguing, and still involving part of modern medicine. Theragnostics is a combination of therapies and diagnostics targeting pathophysiological processes at molecular level using radiopharmaceuticals. It is a valuable resource in efforts to implement precision medicine in clinical practice, but the theragnostic era poses an abundance of challenges. The aim of the present paper study was to analyze some of these challenges in the field of theragnostics, irrespective of their clinical applications. Three experts in this field discussed the balance between the demand, the costs of theragnostics, the need of appropriate infrastructures, and the opportunities for new developments in this area.


KEY WORDS: Precision medicine; Nuclear medicine; Education; Financial support; Interdisciplinary

inizio pagina